A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039) Meeting Abstract
| Authors: | Ansell, S.; Gutierrez, M. E.; Shipp, M. A.; Gladstone, D.; Moskowitz, A.; Borello, I.; Popa-Mckiver, M.; Farsaci, B.; Zhu, L.; Lesokhin, A. M.; Armand, P. |
| Abstract Title: | A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039) |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446803143 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.183.183 |
| Notes: | Meeting Abstract: 183 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
